Related Experiment Videos
[Liver damage caused by drugs]
Deutsche Zeitschrift Fur Verdauungs- Und Stoffwechselkrankheiten
|January 1, 1982
Summary
Drug-induced liver injury (DILI) manifests in various forms, from functional disorders to severe hepatitis. Diagnosis relies on identifying the causative drug, with prognosis generally good after drug withdrawal.
Area of Science:
- Hepatology
- Clinical Pharmacology
- Toxicology
Background:
- Drug-induced liver injury (DILI) is a significant clinical concern.
- DILI presents with diverse clinical and histological patterns, including functional disorders, cholestatic, and hepatitic diseases.
- Distinguishing between direct toxic injury and indirect hypersensitivity reactions is crucial for management.
Purpose of the Study:
- To categorize the clinical presentations of drug-induced liver injury.
- To differentiate between predictable (dose-related) and unpredictable (hypersensitivity) DILI.
- To outline diagnostic approaches and management strategies for DILI.
Main Methods:
- Classification of DILI based on clinical presentation (jaundice, cholestatic, hepatitic patterns).
- Differentiation of injury types: direct toxic (dose-related) versus indirect (hypersensitivity).
- Diagnostic tools including drug re-challenge and in vitro lymphocyte stimulation tests.
Main Results:
- DILI can manifest as functional liver disorders, cholestatic disease, hepatitic disease, or a combination.
- Predictable DILI is dose-dependent, while unpredictable DILI is often hypersensitivity-mediated.
- Special DILI variants include severe fatty liver, peliosis, Budd-Chiari syndrome, liver tumors, and granulomas.
Conclusions:
- The primary treatment for DILI is the cessation of the offending drug.
- Diagnosis can be confirmed by drug re-challenge or lymphocyte stimulation tests.
- While prognosis is generally favorable, some cases may progress to chronic liver disease, including cirrhosis.